Charterhouse in $260m healthcare exit

The US firm, together with Highlander Partners and MTS Health Investors, has generated a 45% IRR by on its investment in Chamberlin Edmonds.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this